The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

Ahead of the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) has outlined the key measures needed to improve UK life science competitiveness, boost UK R ...

India’s pharmaceutical industry is projected to hit $42.9b by 2028 with a compound annual growth rate of 6.3% in local ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Compounding pharmacies can make tirzepatide againIn a reversal, the Food and Drug Administration ...

The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved ...

To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...

and has been granted a new cultivation license by Health Canada. Production is expected to begin in early 2025, marking ...

Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest ...

AstraZeneca has bagged a cardiovascular disease candidate from China's CSPC Pharma in a deal potentially worth $2 billion ...

After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of ...

Teva Pharmaceuticals International GmbH, a unit of Teva Pharmaceutical Industries (TEVA) and mAbxience, a Fresenius Kabi ...